Cargando…
Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure
BIN1 (amphyphysin-II) is a structural protein involved in T-tubule (TT) formation and phosphatidylinositol-4,5-bisphosphate (PIP2) is responsible for localization of BIN1 to sarcolemma. The goal of this study was to determine if PIP2-mediated targeting of BIN1 to sarcolemma is compromised during the...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733645/ https://www.ncbi.nlm.nih.gov/pubmed/35002765 http://dx.doi.org/10.3389/fphys.2021.782767 |
_version_ | 1784627842794913792 |
---|---|
author | Zhou, Junlan Singh, Neha Monnier, Chloe Marszalec, William Gao, Li Jin, Jing Frisk, Michael Louch, William E. Verma, Suresh Krishnamurthy, Prasanna Nico, Elsa Mulla, Maaz Aistrup, Gary L. Kishore, Raj Wasserstrom, J. Andrew |
author_facet | Zhou, Junlan Singh, Neha Monnier, Chloe Marszalec, William Gao, Li Jin, Jing Frisk, Michael Louch, William E. Verma, Suresh Krishnamurthy, Prasanna Nico, Elsa Mulla, Maaz Aistrup, Gary L. Kishore, Raj Wasserstrom, J. Andrew |
author_sort | Zhou, Junlan |
collection | PubMed |
description | BIN1 (amphyphysin-II) is a structural protein involved in T-tubule (TT) formation and phosphatidylinositol-4,5-bisphosphate (PIP2) is responsible for localization of BIN1 to sarcolemma. The goal of this study was to determine if PIP2-mediated targeting of BIN1 to sarcolemma is compromised during the development of heart failure (HF) and is responsible for TT remodeling. Immunohistochemistry showed co-localization of BIN1, Cav1.2, PIP2, and phospholipase-Cβ1 (PLCβ1) in TTs in normal rat and human ventricular myocytes. PIP2 levels were reduced in spontaneously hypertensive rats during HF progression compared to age-matched controls. A PIP Strip assay of two native mouse cardiac-specific isoforms of BIN1 including the longest (cardiac BIN1 #4) and shortest (cardiac BIN1 #1) isoforms as well human skeletal BIN1 showed that all bound PIP2. In addition, overexpression of all three BIN1 isoforms caused tubule formation in HL-1 cells. A triple-lysine motif in a short loop segment between two helices was mutated and replaced by negative charges which abolished tubule formation, suggesting a possible location for PIP2 interaction aside from known consensus binding sites. Pharmacological PIP2 depletion in rat ventricular myocytes caused TT loss and was associated with changes in Ca(2+) release typically found in myocytes during HF, including a higher variability in release along the cell length and a slowing in rise time, time to peak, and decay time in treated myocytes. These results demonstrate that depletion of PIP2 can lead to TT disruption and suggest that PIP2 interaction with cardiac BIN1 is required for TT maintenance and function. |
format | Online Article Text |
id | pubmed-8733645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87336452022-01-07 Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure Zhou, Junlan Singh, Neha Monnier, Chloe Marszalec, William Gao, Li Jin, Jing Frisk, Michael Louch, William E. Verma, Suresh Krishnamurthy, Prasanna Nico, Elsa Mulla, Maaz Aistrup, Gary L. Kishore, Raj Wasserstrom, J. Andrew Front Physiol Physiology BIN1 (amphyphysin-II) is a structural protein involved in T-tubule (TT) formation and phosphatidylinositol-4,5-bisphosphate (PIP2) is responsible for localization of BIN1 to sarcolemma. The goal of this study was to determine if PIP2-mediated targeting of BIN1 to sarcolemma is compromised during the development of heart failure (HF) and is responsible for TT remodeling. Immunohistochemistry showed co-localization of BIN1, Cav1.2, PIP2, and phospholipase-Cβ1 (PLCβ1) in TTs in normal rat and human ventricular myocytes. PIP2 levels were reduced in spontaneously hypertensive rats during HF progression compared to age-matched controls. A PIP Strip assay of two native mouse cardiac-specific isoforms of BIN1 including the longest (cardiac BIN1 #4) and shortest (cardiac BIN1 #1) isoforms as well human skeletal BIN1 showed that all bound PIP2. In addition, overexpression of all three BIN1 isoforms caused tubule formation in HL-1 cells. A triple-lysine motif in a short loop segment between two helices was mutated and replaced by negative charges which abolished tubule formation, suggesting a possible location for PIP2 interaction aside from known consensus binding sites. Pharmacological PIP2 depletion in rat ventricular myocytes caused TT loss and was associated with changes in Ca(2+) release typically found in myocytes during HF, including a higher variability in release along the cell length and a slowing in rise time, time to peak, and decay time in treated myocytes. These results demonstrate that depletion of PIP2 can lead to TT disruption and suggest that PIP2 interaction with cardiac BIN1 is required for TT maintenance and function. Frontiers Media S.A. 2021-12-23 /pmc/articles/PMC8733645/ /pubmed/35002765 http://dx.doi.org/10.3389/fphys.2021.782767 Text en Copyright © 2021 Zhou, Singh, Monnier, Marszalec, Gao, Jin, Frisk, Louch, Verma, Krishnamurthy, Nico, Mulla, Aistrup, Kishore and Wasserstrom. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Zhou, Junlan Singh, Neha Monnier, Chloe Marszalec, William Gao, Li Jin, Jing Frisk, Michael Louch, William E. Verma, Suresh Krishnamurthy, Prasanna Nico, Elsa Mulla, Maaz Aistrup, Gary L. Kishore, Raj Wasserstrom, J. Andrew Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure |
title | Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure |
title_full | Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure |
title_fullStr | Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure |
title_full_unstemmed | Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure |
title_short | Phosphatidylinositol-4,5-Bisphosphate Binding to Amphiphysin-II Modulates T-Tubule Remodeling: Implications for Heart Failure |
title_sort | phosphatidylinositol-4,5-bisphosphate binding to amphiphysin-ii modulates t-tubule remodeling: implications for heart failure |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733645/ https://www.ncbi.nlm.nih.gov/pubmed/35002765 http://dx.doi.org/10.3389/fphys.2021.782767 |
work_keys_str_mv | AT zhoujunlan phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT singhneha phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT monnierchloe phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT marszalecwilliam phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT gaoli phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT jinjing phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT friskmichael phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT louchwilliame phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT vermasuresh phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT krishnamurthyprasanna phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT nicoelsa phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT mullamaaz phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT aistrupgaryl phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT kishoreraj phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure AT wasserstromjandrew phosphatidylinositol45bisphosphatebindingtoamphiphysiniimodulatesttubuleremodelingimplicationsforheartfailure |